Abstract 1643 Structure-Activity Relationship Assessment of Novel HIV-1 Protease Autoprocessing Inhibitors

The HIV-1 protease (PR) is initially produced as part of the Gag-Pol polyprotein precursor, which co-packages with Gag into immature viral particles. Shortly after these particles are released from infected CD4+ cells, the Gag-Pol precursor undergoes autoprocessing. During this process, the embedded precursor PR cleaves at its own N- and C- termini, releasing mature PRs that subsequently cleaves additional sites within Gag and Gag-Pol. Nearly complete cleavage of Gag and Gag-Pol, facilitated by the mature PR, is required to produce fully infectious viral particles.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jbc.2025.109035
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1643 Structure-Activity Relationship Assessment of Novel HIV-1 Protease Autoprocessing Inhibitors

Stephen Ashman, Chaoping Chen, Liangqun Huang, Ryan H. Jeep
Journal of Biological Chemistry
HIV/AIDS drug development and treatment
article

Abstract 1643 Structure-Activity Relationship Assessment of Novel HIV-1 Protease Autoprocessing Inhibitors

Stephen Ashman, Chaoping Chen, Liangqun Huang, Ryan H. Jeep
article en

Abstract

The HIV-1 protease (PR) is initially produced as part of the Gag-Pol polyprotein precursor, which co-packages with Gag into immature viral particles. Shortly after these particles are released from infected CD4+ cells, the Gag-Pol precursor undergoes autoprocessing. During this process, the embedded precursor PR cleaves at its own N- and C- termini, releasing mature PRs that subsequently cleaves additional sites within Gag and Gag-Pol. Nearly complete cleavage of Gag and Gag-Pol, facilitated by the mature PR, is required to produce fully infectious viral particles.

Journal of Biological ChemistryVol. 301(5)
National Cancer Institute (MY)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 83%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 1643 Structure-Activity Relationship Assessment of Novel HIV-1 Protease Autoprocessing Inhibitors — Stephen Ashman, Chaoping Chen, et al. · Journal of Biological Chemistry (2025) | TGRS Research Map | TGRS